Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Specialty Chemicals
DuPont buys OxyMem for water treatment
by Melody M. Bomgardner
January 3, 2020
| A version of this story appeared in
Volume 98, Issue 1
DuPont wrapped up 2019 with one more water treatment purchase, agreeing to take on the 69% of Ireland’s OxyMem that it did not already own. OxyMem, founded in 2013 as a spin-off from University College Dublin, makes membrane-aerated biofilm reactors to treat and purify municipal and industrial wastewater. The company has about 60 employees and a production site in Athlone, Ireland. DuPont also signed deals for Desalitech and the water ultrafiltration businesses of BASF and Evoqua during 2019.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter